Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004239 · ClinicalTrials.gov registry record · Phase 1
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
A Phase 1 study, sponsored by Alliance for Clinical Trials in Oncology.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00004239: Clinical Trial Phase 1 study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00004239 is a Phase 1 study that was terminated before completion, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004239, a Phase 1 study, was terminated before completion, sponsored by Alliance for Clinical Trials in Oncology.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of 506U78 in treating patients who have hematologic cancer and kidney or liver impairment.
Interventions
- DRUG Compound 506U78
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 1999-12 |
| Est. Completion | 2002-01 |
| Phase | Phase 1 |
Why NCT00004239 stopped before completion
NCT00004239 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Compound 506U78 is the first listed.
NCT00004239 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00004239 about?
NCT00004239 is a clinical study titled "506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment". RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of 506U78 in treating patients who have hematologic cancer and kidney or liver impairment.
What is the current status of trial NCT00004239?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 1999-12. Estimated completion is 2002-01.
What interventions are being tested in trial NCT00004239?
The interventions under investigation include: Compound 506U78 (DRUG).
Who is sponsoring clinical trial NCT00004239?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00004239's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia